Completed OBSERVATIONAL NCT02835781

Acellular Dermal Matrix in Breast Reconstruction (Adermbrerec)

Allogenic Acellular Dermal Matrix Use in Patients With Breast Reconstruction

Sponsor: Comenius University

Interventions Acellular dermal matrix implantation

Updated 10 times since 2017 Last updated: Jul 13, 2016 Started: Jan 31, 2010 Primary completion: Jan 31, 2014 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Breast Cancer, this trial is completed. The trial is conducted by Comenius University and has accumulated 10 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Comenius University
University Hospital Bratislava

Data source: University Hospital Bratislava

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bratislava, Slovakia